Logo image of ALDBT.PA

DBT (ALDBT.PA) Stock Fundamental Analysis

EPA:ALDBT - Euronext Paris - Matif - FR001400LO86 - Common Stock - Currency: EUR

0.205  0 (0%)

Fundamental Rating

2

Taking everything into account, ALDBT scores 2 out of 10 in our fundamental rating. ALDBT was compared to 56 industry peers in the Electrical Equipment industry. ALDBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALDBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALDBT has reported negative net income.
ALDBT had a negative operating cash flow in the past year.
ALDBT had negative earnings in each of the past 5 years.
ALDBT had a negative operating cash flow in each of the past 5 years.
ALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

ALDBT's Return On Assets of -26.45% is on the low side compared to the rest of the industry. ALDBT is outperformed by 87.50% of its industry peers.
ALDBT has a Return On Equity of -52.13%. This is amonst the worse of the industry: ALDBT underperforms 83.93% of its industry peers.
Industry RankSector Rank
ROA -26.45%
ROE -52.13%
ROIC N/A
ROA(3y)-33.36%
ROA(5y)-29.74%
ROE(3y)-63.54%
ROE(5y)-60%
ROIC(3y)N/A
ROIC(5y)N/A
ALDBT.PA Yearly ROA, ROE, ROICALDBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

ALDBT's Gross Margin of 30.74% is on the low side compared to the rest of the industry. ALDBT is outperformed by 60.71% of its industry peers.
ALDBT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALDBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-25.54%
ALDBT.PA Yearly Profit, Operating, Gross MarginsALDBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALDBT has more shares outstanding than it did 1 year ago.
ALDBT has less shares outstanding than it did 5 years ago.
ALDBT has a worse debt/assets ratio than last year.
ALDBT.PA Yearly Shares OutstandingALDBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALDBT.PA Yearly Total Debt VS Total AssetsALDBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.10, we must say that ALDBT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.10, ALDBT is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
ALDBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.1
ROIC/WACCN/A
WACC5.22%
ALDBT.PA Yearly LT Debt VS Equity VS FCFALDBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 1.02 indicates that ALDBT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, ALDBT is not doing good in the industry: 80.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.66 indicates that ALDBT may have some problems paying its short term obligations.
ALDBT's Quick ratio of 0.66 is on the low side compared to the rest of the industry. ALDBT is outperformed by 82.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
ALDBT.PA Yearly Current Assets VS Current LiabilitesALDBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

ALDBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.
ALDBT shows a decrease in Revenue. In the last year, the revenue decreased by -3.98%.
The Revenue has been growing slightly by 2.99% on average over the past years.
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y39.23%
Revenue growth 5Y2.99%
Sales Q2Q%-3.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ALDBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.46% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year170836%
Revenue Next 2Y4524.17%
Revenue Next 3Y1293.96%
Revenue Next 5Y10.46%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALDBT.PA Yearly Revenue VS EstimatesALDBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
ALDBT.PA Yearly EPS VS EstimatesALDBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2024 2025 2026 2027 -2K -4K -6K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALDBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDBT.PA Price Earnings VS Forward Price EarningsALDBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDBT.PA Per share dataALDBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALDBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DBT

EPA:ALDBT (6/17/2025, 7:00:00 PM)

0.205

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.03M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB 0.08
EV/EBITDA N/A
EPS(TTM)-5.7
EYN/A
EPS(NY)-4.97
Fwd EYN/A
FCF(TTM)-2.37
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS2.08
BVpS2.88
TBVpS2.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.45%
ROE -52.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.74%
FCFM N/A
ROA(3y)-33.36%
ROA(5y)-29.74%
ROE(3y)-63.54%
ROE(5y)-60%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-25.54%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z -0.1
F-Score3
WACC5.22%
ROIC/WACCN/A
Cap/Depr(3y)331.85%
Cap/Depr(5y)327.48%
Cap/Sales(3y)38.5%
Cap/Sales(5y)30.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y39.23%
Revenue growth 5Y2.99%
Sales Q2Q%-3.85%
Revenue Next Year170836%
Revenue Next 2Y4524.17%
Revenue Next 3Y1293.96%
Revenue Next 5Y10.46%
EBIT growth 1Y-4.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89198.2%
EBIT Next 3Y-666.44%
EBIT Next 5Y27.49%
FCF growth 1Y-51.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.85%
OCF growth 3YN/A
OCF growth 5YN/A